How Decision Analytics from WhizAI Benefit Life Sciences Teams
- Field Sales:
Decision analytics can inform sales reps about a healthcare provider’s prescribing pattern and the materials from the company that caught the prescriber’s attention. With these insights, the rep can personalize conversations and positively influence prescription rates.
- Sales Managers:
WhizAI makes it easy for sales managers to take a big-picture view of sales in their regions as well as drill down to specific healthcare provider activity and individual sales rep performance.
- Market Access:
Decision analytics from WhizAI provides intelligence about competitor activity, current and historical market activity, and the company’s market share. This information will help a market access team improve formulary or patient enrollments.
- Patient Services:
Using patient data from diagnosis to recovery, the patient services team to improve adherence and patient outcomes.
How WhizAI Overcomes Life Science Data Challenges
WhizAI is designed to overcome a prevalent challenge among life sciences companies: How to achieve data ROI.
Companies invest millions into data acquisition and analytics but often fail to move the needle on business performance. When companies use traditional BI dashboard solutions for decision analytics, the answer that life science teams need can take weeks, decreasing agility. Additionally, most employees aren’t data scientists, so they rely heavily on their data or IT teams for analytics and assistance using dashboards.
WhizAI changes the unit of work from a dashboard to a question. WhizAI’s hybrid natural language processing (NLP) engine understands how life science employees across lines of business communicate. Users don’t have to phrase questions in specific ways or use keywords. They can ask questions naturally, and WhizAI responds with relevant, contextual insights and automatically chooses the optimal visualization to present information. Furthermore, if users need deeper insights, all they need to do is ask a follow-up question, and WhizAI responds with insights that take their roles, the regions in which they work, and their product focus into account.
As a result, companies using WhizAI report a decrease in end-to-end development time, increased efficiency, cost savings, and faster time from data acquisition to insights. WhizAI also contributes to greater job satisfaction among employees.
WhizAI Decision Analytics Features
Pre-Trained for Life Sciences
WhizAI is pre-trained for the life sciences domain, so it can analyze life sciences data from primary and secondary sources right out of the box. In addition, because it’s pre-trained, deployment is faster than with other AI analytics platforms, reducing the time from months to weeks.
BI dashboards analyze a limited number of data sources and data volumes. But WhizAI scales to an unlimited number of data sources, can base decision analytics on petabytes of data, and still provides insights in less than a second.
WhizAI is designed for enterprise use. Enterprise features include integration with the business applications that life sciences teams commonly use, such as Veeva, Microsoft Teams, and Salesforce. It also has enterprise-grade security and access control via multifactor authentication (MFA) and multilanguage capabilities.
WhizAI’s microservices architecture provides uptime and flexibility to ensure that users always have access to decision analytics when they need them, regardless of a question’s complexity. WhizAI also monitors security intelligence resources to stay on top of vulnerabilities and keep the platform secure.
Focus on Autonomy
WhizAI is structured to support the augmented life sciences analytics consumer, delivering insights with minimal assistance from the data or IT team and encouraging user adoption. When users – from lines of business to the C-suite – see how easy it is to build decision analytics into their workflows and the impact it makes on their job performance, they make WhizAI a part of day-to-day processes. Companies that implement WhizAI see user adoption as high as 100%.
To learn how decision analytics via WhizAI will benefit your life science company
Gartner Reports AI in Clinical Development is Only 2-5 Years from Mainstream Adoption
WhizAI is recognized as a Sample Vendor for AI in clinical development, a high-benefit technology already seeing market penetration.
Augmented Analytics is “On the Rise” on Gartner’s 2022 Hype Cycle for Life Science Commercial Operations
The Gartner® 2022 Hype Cycle™ for Life Science Commercial Operations introduces a new category, Augmented Analytics, this year. WhizAI is listed as a sample vendor in the Augmented Analytics category in this Hype Cycle. This summary report covers the following highlights.
Where Gartner Positions Natural Language Query on the Hype Cycle and What It Means for Life Sciences
Gartner® 2022 Hype Cycle™ for Natural Language Technologies (NLT) shows natural language query (NLQ) adoption is accelerating. WhizAI was recently recognized as a Sample Vendor in the Natural Language Query category in several Gartner Hype Cycles:
Market Access Team Stays Ahead of the Curve with WhizAI-Powered Insight-Driven Decisions
After investing in self-service analytics platforms, this global pharmaceutical company discovered the ease, usability — and ROI — of WhizAI.
Global Pharma Patient Services Team Manages 20,000+ Patients with Insights from WhizAI
This patient services team now has visibility into the entire patient journey, identify risks, and increase productivity by a factor of five.